[Federal Register Volume 60, Number 17 (Thursday, January 26, 1995)]
[Notices]
[Page 5230]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-1917]



-----------------------------------------------------------------------


SECURITIES AND EXCHANGE COMMISSION

Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration; (Diagnostic Health Services, Inc., Common Stock, $.01 
Par Value, Common Stock Purchase Warrants) File No. 1-11984

January 19, 1995.
    Diagnostic Health Services, Inc. (``Company'') has filed an 
application with the Securities and Exchange Commission 
(``Commission''), pursuant to Section 12(d) of the Securities Exchange 
Act of 1934 (``Act'') and Rule 12d2-2(d) promulgated thereunder, to 
withdraw the above specified securities (``Securities'') from listing 
and registration on the Boston Stock Exchange, Inc. (``BSE'').
    The reasons alleged in the application for withdrawing these 
Securities from listing and registration include the following:
    Presently, the Company has listed the Securities on the Exchange 
and on the NASDAQ Small Cap Market. The Company wishes to have the 
Securities delisted from the Exchange due to the fact the Securities 
have not been actively traded on the Exchange at any time since the 
inception of their listing, and the continued listing of the Securities 
on the Exchange will constitute an unnecessary expenditure of the 
Company's capital.
    Any interested person may, on or before February 9, 1995, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549, facts bearing upon whether the 
application has been made in accordance with the rules of the BSE and 
what terms, if any, should be imposed by the Commission for the 
protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Margaret H. McFarland,
Deputy Secretary.
[FR Doc. 95-1917 Filed 1-25-95; 8:45 am]
BILLING CODE 8010-01-M